Related Experiment Video
Updated: Nov 4, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Yiwen Zhang1, Yingshi Chen1, Yuzhuang Li1
1Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, 510080, Guangzhou, Guangdong, China.
Abstract:
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has claimed over 2 million lives worldwide. Although the genetic sequences of SARS-CoV and SARS-CoV-2 have high homology, the clinical and pathological characteristics of COVID-19 differ significantly from those of SARS. How and whether SARS-CoV-2 evades (cellular) immune surveillance requires further elucidation. In this study, we show that SARS-CoV-2 infection leads to major histocompability complex class Ι (MHC-Ι) down-regulation both in vitro and in vivo. The viral protein encoded by open reading frame 8 (ORF8) of SARS-CoV-2, which shares the least homology with SARS-CoV among all viral proteins, directly interacts with MHC-Ι molecules and mediates their down-regulation. In ORF8-expressing cells, MHC-Ι molecules are selectively targeted for lysosomal degradation via autophagy. Thus, SARS-CoV-2-infected cells are much less sensitive to lysis by cytotoxic T lymphocytes. Because ORF8 protein impairs the antigen presentation system, inhibition of ORF8 could be a strategy to improve immune surveillance.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection down-regulates major histocompatibility complex class I (MHC-I) via its ORF8 protein. This viral mechanism helps SARS-CoV-2 evade immune detection by cytotoxic T lymphocytes.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- COVID-19, caused by SARS-CoV-2, presents distinct clinical features compared to SARS.
- Understanding SARS-CoV-2 immune evasion mechanisms is crucial for combating the pandemic.
Purpose of the Study:
- To investigate how SARS-CoV-2 evades cellular immune surveillance.
- To identify specific viral components involved in immune evasion.
Main Methods:
- In vitro and in vivo studies of SARS-CoV-2 infected cells.
- Analysis of major histocompatibility complex class I (MHC-I) expression.
- Investigation of the role of SARS-CoV-2 ORF8 protein.
Main Results:
- SARS-CoV-2 infection down-regulates MHC-I expression in infected cells.
- The viral ORF8 protein directly interacts with MHC-I, leading to its degradation via autophagy.
- ORF8-expressing cells show reduced sensitivity to cytotoxic T lymphocyte lysis due to impaired antigen presentation.
Conclusions:
- SARS-CoV-2 utilizes its ORF8 protein to down-regulate MHC-I, thereby evading cytotoxic T lymphocyte surveillance.
- Targeting ORF8 could be a potential therapeutic strategy to enhance immune responses against SARS-CoV-2.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Leaky Scanning
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Regulation of the Unfolded Protein Response
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

